MarketCapTrends
TENX

Tenax Therapeutics Inc. (TENX)

NASDAQ · Healthcare

Tenax Therapeutics Inc. annual/quarterly shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Tenax Therapeutics Inc. shareholder equity for the quarter ending December 31, 2025 were 97.1M, a 5.52% increase year-over-year.
  • Tenax Therapeutics Inc. shareholder equity for 2025 were 97.1M, a 5.52% increase from 2024.
  • Tenax Therapeutics Inc. shareholder equity for 2024 were 92.0M, a 436.69% increase from 2016.
  • Tenax Therapeutics Inc. shareholder equity for 2016 were 17.1M, a 75.66% decrease from 2015.
  • Tenax Therapeutics Inc. shareholder equity for 2015 were 70.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Tenax Therapeutics Inc. Annual Shareholder Equity (Millions of US $)
2025$97
2024$92
2016$17
2015$70
2014$83
2013$-2
2012$-0
2011$-4
Tenax Therapeutics Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$97
2024-12-31$92
2016-12-31$17
2015-04-30$70
2014-04-30$83
2013-04-30$-2
2012-04-30$-0
2011-04-30$-4

Tenax Therapeutics Inc. Shareholder Equity — FAQ

Tenax Therapeutics Inc. (TENX) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TENX's shareholder equity history?

The chart and table above show Tenax Therapeutics Inc.'s shareholder equity by year and by quarter, including the growth rate.